AJ Vaccines A/S: Financial statements 2025
CVR: 37911143
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
AJ Vaccines A/S (CVR 37911143) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 389,681,000 and a net result of DKK -483,351,000 compared with DKK -807,117,000 the year before. That is a decrease of 5.6% compared with the year before. The profit margin was -124%. Equity in the 2025 report amounted to DKK 288,465,000. The solvency ratio was 33.5%. The company had 451 employees in the financial year.
- Revenue
- DKK 389,681,000
- Gross Profit
- DKK -220,277,000
- Profit/Loss
- DKK -483,351,000
- Equity
- DKK 288,465,000
- Total Assets
- DKK 861,206,000
- Employees
- 451
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 389.7M | -220.3M | -483.4M | 288.5M | 451 |
| 2024 | 413M | -587M | -807.1M | 501.9M | 581 |
| 2023 | 468.9M | -30.7M | -243M | 1B | 577 |
| 2022 | 421M | -66M | -268.1M | 994.7M | 556 |
| 2021 | 351.9M | -304M | -486.4M | 815.9M | 558 |
Official annual report
How creditworthy is AJ Vaccines A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
AJ Vaccines A/S has published its annual report for 2024. Revenue came to DKK 412,969,000, and the net result was DKK -807,117,000.
About AJ Vaccines A/S
AJ Vaccines A/S is a Danish company of the type Aktieselskab based in København S, founded in 2016. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Aktieselskabet af august 2016. The management consists of Ole Vahlgren. The board consists of Abdulaziz Abdulhamid Abdulrhman Albassam (chair), Mohammed Ali A Alesayi, Mustafa Nasir Farooki and Saddam Abdulqawi Hussein Alhumaikani. The company is owned by AJ Vaccines Holding ApS. The company has 499 employees (2026). In 2025, the company reported revenue of DKK 389,681,000 and a net result of DKK -483,351,000 compared with DKK -807,117,000 the year before. Equity in the 2025 report amounted to DKK 288,465,000.
